addmedica - Chairman's foreword

addmedica is dedicated to providing high medical value to physicians, patients, and managed care organizations, by developing, registering and marketing a wide range of medical products in several rare and debilitating diseases. Our areas of interest comprise :
-       wound healing, tissue growth, cell culture
-       organ transplant, tissue replacement
-       genetic diseases, drug or substitute therapy, cell or gene therapy

The company is proud to offer its current range of products in the fields of lung transplantation, wound healing and deep burn care. The first drug indicated in the Sickle Cell Disease in Europe is also approved and already launched in several European countries.

addmedica is constantly looking for new opportunities and partnerships, to develop and commercialize products with high medical demand.

As a result of its know-how, its commitment and its positioning, addmedica is ready to become a leading firm for the provision of medical products and innovative techniques for rare diseases with the best quality of services.

François Anger
Chairman